Exponent, Inc. (EXPO)
NASDAQIndustrialsEngineering & ConstructionSnapshot 2026-09-04
$68.35-2.43%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsEngineering & ConstructionSnapshot 2026-09-04
Warn: Primary pillar under pressure — Operating margin near 27%: FY26 operating margin 20.6% vs 27% target.
Exponent grows sales about 8% a year. Profit margins stay near 27%. The company returns cash with dividends and buybacks. Leadership changes are managed well.
Operating income fell from $44.4M to $41.4M in the last year. Leadership churn may hurt strategy. Revenue growth could slow below expectations.
The price is about 15% above our fair value near $54. Analysts expect about 8% revenue growth. Our view aligns with these expectations but sees risk in margin and execution.
Breaks if: No further share repurchase authorization or buybacks in 2026
Exponent has increased its share repurchase authorization by $50 million, adding to the existing $17.7 million.
Breaks if: Dividend per share falls below $0.31 in 2026
Breaks if: Leadership changes cause operational setbacks or strategy shifts
Breaks if: Operating margin falls below 26% in FY26
Breaks if: YoY revenue growth falls below ~7.9% in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
EXPO represents a durable compounder in the consulting services sector. The current thesis state is intact, supported by strong recent financial performance, but it faces challenges from sector dynamics.
The market currently prices EXPO at a premium compared to peers, reflecting elevated expectations. This premium is seen as unjustified given the company's recent mixed signals and execution quality.
Fundamentals are likely to remain stable, with management focused on driving revenue growth and maintaining strong operating margins. However, there is an elevated risk due to the potential for guidance cuts, which could impact credibility.
The long-term thesis hinges on sector performance, particularly the results of key competitors like PWR, FIX, and EME. If these companies continue to perform well, it could support EXPO's growth; however, any negative shifts could pose risks.
In the next 1 to 3 years, EXPO's performance will depend on its ability to navigate sector challenges while maintaining its growth trajectory. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports a positive outlook. Additionally, the investment in talent and leadership reinforces growth objectives. There are no current threats impacting the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.